research grants awarded

This All Volunteer Charity Has Raised and Awarded $15 million for Cancer Research and Patient Care in Colorado

2020 Research Grants Awarded by Cancer League of Colorado

  2020 CANCER LEAGUE OF COLORADO RESEARCH GRANTS  
     
PRINCIPAL INVESTIGATOR TITLE OF PROJECT  AMOUNT FUNDED
     
Zdenek Andrysik, PhD Exploring strong synergism of targeted p53 activation and translation inhibition in colorectal cancer  $     30,000
Diana M. Cittelly, PhD Function of Ephrin B Signaling in Breast cancer brain metastasis  $     30,000
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD The role of alpha-1 antitrypsin in cancer immunotherapy  $     60,000
Zachary Graff, MD Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia  $     30,000
Paula Jedlicka, MD, PhD Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma  $     30,000
Molishree Joshi, PhD A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma  $     30,000
Senthilnath Lakshmana Chetty, PhD Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation  $     30,000
Maureen Lynch, Phd & Philip Owens, PhD The role of exercise in breast cancer bone metastasis  $     60,000
Ryan Marker, PhD Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors  $     30,000
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD The Tumor Microenvironment as a Critical  Regulator of Targeted Therapy in ALK Positive Lung Cancer  $     60,000
Swati G. Patel, MD, MS Identification of Hereditary Cancer Syndromes through Advanced Polyps  $     30,000
Rebecca Schweppe, PhD The role of Nuclear FAK in Thyroid Cancer  $     30,000
Matthew Tallaferro, PhD Control of cell division through centrosomal RNA localization  $     30,000
Christine Towers, PhD Identifying novel regulators of mitochondrial turn over  $     30,000
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells  $     60,000
Breelyn Wilky, MD & Eduardo Davila, PhD Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma  $     60,000
  TOTAL  $   630,000

2019 Research Grants Awarded by Cancer League of Colorado

Click Here to Download as .pdf

  Cancer League of Colorado  
  2019 Research Grants Awarded  
     
PRINCIPAL TITLE OF PROJECT  AMOUNT 
INVESTIGATOR    AWARDED 
     
Adam Mueller, MD, PhD Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer  $              30,000
Cem Altunbas, PhD High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy  $              30,000
Heather Brechbuhl, PhD Defining reversible tumor traits in the obese microenvironment  $              30,000
Isabel Schlaepfer, PhD Role of fat oxidation via CPT1A in immunological response to prostate cancer  $              30,000
Jay Hesselberth, PhD Single-cell methods to measure functional heterogeneity  $              30,000
John Tentler, PhD Cancer Research Summer Fellowship Program  $              30,000
Matthew Sikora, PhD Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma  $              30,000
Mayumi Fujita, MD, PhD  & Donald Backos, PhD Somatic mutations in inflammasome genes in melanoma  $              60,000
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma  $              60,000
Neil Box, PhD Regulation of p53 in tanning  $              30,000
Paul Norman, PhD Natural Killer cells can protect from developing leukemia  $              30,000
Rajeev Vibhakar, MD, PhD, MPH Role of CDK7 in medulloblastoma  $              30,000
Carol Sartorius, PhD PR-RAR downregulation of protein synthesis and cell growth in breast cancer  $              30,000
Shi-Long Lu, MD, PhD and Daniel Frank, PhD Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy  $              60,000
Stephen Keysar, PhD Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation  $              30,000
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG  $              60,000
Yiqun Shellman, PhD & Martin McCarter, MD Targeting anti-apoptotic pathways to improve immunotherapies for melanoma  $              60,000
Zachary Levi Watson, PhD Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer  $              30,000
     $            690,000

Click Here to Download a .pdf

    2018 Cancer League of Colorado    
    Research Grants    
PRINCIPAL        
INVESTIGATOR   TITLE OF PROJECT    AMOUNT 
         
Benjamin Bitler, PhD   Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance    $     30,000
Zhangguo Chen, PhD   Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy    $     30,000
Mair E.A. Churchill, PhD   Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis    $     30,000
Maria Jose Contreras, PhD   Mechanisms of TDM1/radiation-induced toxicity in brain metastases    $     30,000
Scott Cramer, PhD and James Costello, PhD   Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7    $     60,000
Nathan Dahl, MD   Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma    $     30,000
Jennifer DeLuca, PhD   Targeting Kinetochore Dysfunction in Cancer Cells    $     30,000
Nicholas Forman, MD   Characterization of heterogeneous tumor subpopulations in childhood ependymoma    $     30,000
Jennifer Hintzsche, PhD   Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer    $     30,000
Courtney Jones, PhD   Targeting relapse leukemia stem cells through inhibition of NAD synthesis    $     30,000
Adwitiya Kar, PhD and Margaret Wierman, MD   Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma    $     30,000
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD   Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma    $     60,000
Jessica Lake, MD, MPH   IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas    $     30,000
Christopher Lieu, MD and Todd Pitts, MD   Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer    $     60,000
Martin McCarter, MD   Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function    $     30,000
David Ryan Ormond MD   Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety    $     30,000
Rebecca Schweppe, PhD   Cooperative Src and MAP Kinase Signaling in Thyroid Cancer    $     30,000
Jill Slansky PhD   Functional activation of low-affinity T cells in the tumor    $     30,000
John Tentler, PhD   Cancer Research Summer Fellowship Program    $     30,000
David Thomas, PhD and Mark Borden, PhD   X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy    $     30,000
Raul M. Torres, PhD   Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid    $     30,000
Linda Van Dyk, PhD   Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis    $     30,000
         $   750,000

2017 Cancer League of Colorado Research Grants

Click Here to Download as a .pdf

  2017 Cancer League of Colorado  
  Research Grants  
     
PRINCIPAL TITLE OF PROJECT AMOUNT
INVESTIGATOR    
     
David Bentley, PhD Deregulation of mRNA 3′ end formation in breast cancer $30,000
Eric Clambey, PhD High-dimensional analysis of effector T cell mechanisms in lung cancer $30,000
James Costello, PhD Measuring chromosome-conformation abnormalities within a single cancer cell $30,000
Kasey Couts, PhD Improving targeted therapy in melanomas with BRAF fusions $30,000
James DeGregori, PhD Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer $30,000
Heide L. Ford, PhD Role of Six2 in mediating late stage metastasis $30,000
Todd Hankinson, MD, MBA Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression $27,976
Britta Jacobsen, PhD Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer $30,000
Paul Jedlicka, MD, PhD The epigenetic modifiers PHF2 and PhF8 in Ewing Sarcoma $30,000
Sana Karam, MD, PhD Enhancing the Effects of Immune Checkpoint Blockade with Radiation Therapy in Head and Neck Cancer $30,000
Hyunmin Kim, PhD Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer $30,000
Daniel V. LaBarbera, PhD and Wells A. Messersmith, MD Patient Derived Tumor Organoids for Personalized and Targeted Colorectal Cancer Therapeutics $60,000
Jung-Jae Lee, PhD Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer $29,835
Changwei Liu, PhD Validating USP35 as an anticancer drug target $30,000
Traci R. Lyons, PhD and      Beth Taburini, PhD Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity $60,000
Rebecca Schweppe, PhD Targeting FAK and Src in Thyroid Cancer $30,000
Matthew J. Sikora, PhD Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma $30,000
Jenna Sopfe, MD Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population $29,961
Darinee Tippimanchai, PhD Targeting IL17 in Kras mutant lung cancer $30,000
Dan Theodorescu, MD, PhD Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients $30,000
John Tentler, PhD Cancer Research Summer Fellowship Program $30,000
Jing H. Wang, MD, PhD Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses $30,000
Amanda C. Winters, MD, PhD Validating CD123 as a Leukemia Stem Cell Marker and Therapeutic Target in Pediatric AML $30,000
  TOTAL $747,772

 

Cancer League 2016 Research Grants

Click to view as a .pdf

INVESTIGATOR TITLE OF PROJECT AMOUNT FUNDED
     
Scott Alper, PhD and Daniel Pollyea, MD, MS Splicing gene mutations and infection in MDS patients $30,000
Diana Cittelly, PhD Role of TRKB/BDNF axis in brain metastatic breast cancer $30,000
James DeGregori, PhD Examining oncogenic clonal expansions in the context of aging $30,000
S. Gail Eckhardt, MD & Aik Choon Tan, PhD Exploiting Patient Derived Cancer Models for Novel Immunotherapy Regimens $60,000
Lauren Fishbein, MD, PhD Investigating the role of MAML3 in neuroendocrine tumorigenesis $30,000
Matthew Galbraith, PhD Novel genes mediating cancer cell survival and proliferation in hypoxic conditions $30,000
Arthur Gutierrez-Hartman, MD Elucidating the Mechanism by which ESE-1 Controls Estrogen Mediated Tumorigenesis in HER2 + ER + Luminal B Human Breast Cancer $30,000
Lynn Heasley, PhD and Raphael Nemenoff, PhD Identification of TME-Derived Pathways for Co-Targeting in FGFR1-Dependent Lung Cancers $60,000
Britta Jacobsen, PhD Examining the role of Mucin-2 in breast cancer $30,000
Howard Li, MD Mechanisms of Resistance to T Cell-Mediated Immunotherapy in Non-Small Cell Lung Cancer $30,000
Shi-Long Lu, PhD and John Song, MD Role of microRNA methylation and its application as a biomarker in head and neck cancer $60,000
Christopher Porter, MD The Role of ETV6 in B lymphopoiesis $30,000
Dohun Pyeon, PhD Role of Antitumor Chemokines in Clearance of Head and Neck Cancer $30,000
William Robinson, MD, PhD CARD10 and NFkB signaling in melanoma: Implications for immunotherapy $30,000
Isabel Schlaepfer, PhD Role of androgens on lipid catabolism in prostate cancer $30,000
Joseph Sottnik, PhD Therapeutic targeting of organ specific tumor growth and metastases through functional genomics $30,000
John Tentler, PhD Cancer Research Summer Fellowship Program $30,000
Tamara Terzian, PhD p53 in melanoma $30,000
Melanie Vincent, PhD Targeting Eya2 to inhibit c-Myc driven Medulloblastoma Tumor $30,000
Christian Young, PhD Targeting paracrine stromal factors induced by P13K inhibitor therapy in head and neck cancer $30,000
Yuwen Zhu, PhD Targeting the novel immune checkpoint CD112R for cancer therapy $30,000
  TOTAL $720,000

Cancer League of Colorado 2015 Research Grants Awarded

Cancer League of Colorado 2015 Research Grants Awarded

Click Here to Download Cancer League of Colorado Research Grants 2015 as a .pdf

 

PRINCIPAL INVESTIGATOR  2nd PRINCIPAL INVESTIGATOR PROJECT AMOUNT
Steve Anderson, PhD Carol Sartorius, PhD Targeting breast cancer stem cells by inhibiting glucose metabolism       $60,000
Robert Annett, PhD Nicholas Foreman, MD Novel Assessment of Neuropsychological Difficulties in Children (NAND-Child)        $60,000
Neil Box Lori Crane, PhD Determining the utility of UV photography as a quantitative tool for evaluating sun exposure history of children and adolescents        $60,000
Anna Capasso, MD   Combination Therapies for Young Patients with late state colorectal cancer        $30,000
James Costello, PhD   Integrating Transcriptional Regulatory And Metabolic Networks To Characterize Bladder Cancer Cellular Response to Chemotherapies        $30,000
Elan Eisenmesser, PhD   The anti-cancer mechanism of Il-37        $30,000
Mayumi Fujita, MD, PhD Jingshi Shen, PhD Homozygously deleted chromosomal changes in metastatic melanoma        $60,000
Dr. MoumitaGhosh   A novel preclinical model to test Iloprost and PPAR delta antagonist in lung cancer chemoprevention        $30,000
MarkGregory, PhD   Redox-targeted therapy for the treatment of FLT3 mutated leukemia        $30,000
Jennifer Hintzsche, PhD William Robinson, MD, PhD Identifying Molecular Targets in Melanoma Resistant to Braf/Mek Combination Therapy        $30,000
Sana Karam, MD, PhD   Role of EphB4 in radiosensitization in PDX model of head and neck cancer        $30,000
Jeffery Kieft, PhD   How does miRNA modulation of mRNA structure regulate production of a pro-tumor chemokine receptor?        $30,000
Katja Kiseljak-Vassiliades, DO StephenLeong, MD Approaches to Targeted Therapy in Adrenal Carcinogenesis        $60,000
Laurel L. Lenz, PhD   Activation of NK cells for immunotherapy of lung tumors        $30,000
Karen Ryall, PhD Aik ChoonTan, PhD Systems analysis of EGFR-inhibitor induced kinome reprograming and EMT in non-small cell lung cancer        30,000
John Tentler, PhD   Cancer Research Summer Fellowship Program        30,000
Dan Theodorescu   Identification and characterization of GON4L as a novel regulator of oncogene CD24 in bladder cancer        $30,000
Andrew Thorburn, PhD Joaquin M Espinosa, PhD Selective targeting of drug-induced autophagy to improve cancer therapy       $ 60,000
Raul Torres, PhD   Tumor-derived LPA immune suppression of CD8 T cell tumor immunity        $30,000
Elizabeth Wellberg, PhD   The role of the Androgen Receptor in obesity-associated postmenopausal breast cancer        $30,000
Margaret Wierman, MD Rajeev Vibhakar, MD Role of Mammalian Sterile 20 like kinase 4 (MSTA) in Pediatric Brain Cancer        $60,000
    TOTAL $840,000

2014 Research Grants Awarded

2014 Research Grants Awarded

Download Research Grants 2014 as a .pdf

Cancer League of Colorado 2014 Research Grants  
Researcher Organization Grant Awarded
Carol Sartorius, PhD University of Colorado Denver Quiescent estrogen receptor positive cells as a source of breast cancer recurrence                   $30,000
Tobia Neff, MD University of Colorado Denver Novel Therapeutic Targets in Ezh2-Inactivated Acoute Leukemia                     $30,000
Christopher Porter, MD/ Jill Slansky, PhD University of Colorado Denver Leukemia-cell Calcineurin as a central mediator of immune evasion                     $60,000
John Tentler, PhD University of Colorado Denver Cancer Research Summer Fellowship Program                     $30,000
Lingdi Zhang, PhD University of Colorado Denver The effect of inhibiting splicing factor Snu114 in cancer                     $30,000
Rui Zhao, PhD / Heide Ford, PhD University of Colorado Denver Developing stapled peptides for breast cancer theraphy                     $60,000
James Finigan, MD / Aik Choon Tan, PhD National Jewish Hospital Kinome Essential Screen for Discovery of Novel Targets in Small Cell Lung Cancer                     $60,000
Maranke Koster, PhD University of Colorado Denver Consequences of TP63 loss on human skin squamous cell carcinogenesis                     $30,000
James Hagman, PhD National Jewish Hospital Functional analysis of EBF1:PDGFRB, a novel oncoprotein                     $30,000
Jing Hong Wang, PhD University of Colorado Denver A Novel Approach to Reveal the Impact of Genetic Mutations on Cancer Genome Stability                     $30,000
Martin McCarter, MD University of Colorado Denver Combined ATRA and Ipillmuma treatment to reduce immunosuppression in melanoma patients                     $30,000
Rebecca Schweppe, PhD / Bryan Haugen, MD University of Colorado Denver Targeting Src kinase with dasatinib in thryoid cancer                     $60,000
Lee Niswander, PhD / Heide Ford, PhD
University of Colorado Denver Grhl2 Developmental Network to Identify Novel Suppressors of EMT in Breast Cancer                     $60,000
Daniel Merrick, MD Denver Research Inst. Characterizing the activation status of inflammatory infiltrates in persistent and regressive premalignanat bronchial dysplasia                     $30,000
Cheng-jun Hu, PhD University of Colorado Denver Role of PBRM1 mutation in clear cell renal cell carcinoma                     $30,000
Michael Morgan, PhD University of Colorado Denver Autophagy and RIP#-dependent necrosis in cancer chemotherapy                     $30,000
Rytis Prekeris, PhD / Dr. Xiao-Jing Wang
University of Colorado Denver Elucidating the roles of midbodies during squamous cell carcinoma progression                     $60,000
Sunny Guin, PhD University of Colorado Denver HAS2 is a critical effector for AGL mediated regulation of tumor growth                     $30,000
Dohun Pyeon, PhD University of Colorado Denver The Roles of APOBEC3 in Human Papillomavirus Infection and Oncogenesis                     $30,000
Paul Jedlicka, PhD University of Colorado Denver Evaluation of pharmacologic inhibition of histone demethylases in Ewing Sarcoma                     $30,000
Tullia Bruno, PhD University of Colorado Denver The function of tumor infiltrating B cells in non small cell lung cancer patients                     $30,000
Total $810,000    

2013 Research Grants Awarded

2013 Research Grants Awarded

Download the 2013 the Rsearch Grants Awarded by the Cancer League of Colorado as a .pdf

Applicant 2013 Research Grant   Grant Amount
John Tentler PhD Cancer Research Fellowship Program UCD  $30,000
Eric Clambey PhD Role of hypoxic signaling in influencing T cell mediated cancer immunotherapy UCD $30,000
Elaine Lam and Aik Choon Tan Genomic sequencing-based predictive biomarker development for targeted anti- cancer therapies UCD $60,000
Ke Jun Han PhD with Changwei Liu Regulating EGFR protein levels by a deubiquitinaying enzyme in cancer cells UCD $30,000
Marybeth Sechler H3K9 histone demethylases in Ewing Sarcoma UCD $30,000
Chu An Wang, Dept. of Pharm. Targeting Vascular Endothelial Growth Factor C in the cancer stem like population sensitizes breast Ccncer cells to oxidize stress and onhibits tumor progression UCD $30,000
Todd McKinley director Collaborative Project to increase accrual to cancer trials CCRP $30,000
Thomas Rodger, postdoctoral fellow Targeting the Kynurenine Pathway to inhibit breast cancer metastases UCD $30,000
Xuedong Liu PhD Profile specific HDAC inhibitors for triple negative breast cancer UC Boulder $30,000
Nicholas Foreman MD Development of Antibody as immunotherapy for pediatric brain tumors UCD $30,000
Sunny Guin, Fellow AGL, a glycogen debranching gene is a novel suppressor of bladder cancer growth UCD $28,500
Elizabeth Kessler MD, Fellow Effects of Androgen Deprivation Therapy on geriatric health and physical function in men over 70 years of age with prostate cancer UCD $30,000
Lindsey Hoffman DO Unique patterns of progression in recurrent pediatric Ependymoma UCD $30,000
York Miller MD and Mark Geraci MD Bronchial Somatic Chromosomal Alterations in lung cancer risk UCD $30,000
Quinghong Zang PhD Targeting Melanoma Photocinogeneses by blocking C+BP1 UCD $30,000
Philip Reigan PhD and Heide Ford PhD Novel allosteric inhibitors of Eya 2 phosphate for treatment of metastatic breast cancer UCD $60,000
Steven Anderson and Mary Reyland Protein Kinase C Delta and breast cancer therapeutics UCD $30,000
Shi-Long Lu MD In Vivo modeling of salivary gland tumor formation progression UCD $30,000
Robert Keith MD with Gregory Hickey, Fellow Pre-Clinical Investigation of Treprostinil as a Cemopreventive Agent for non-small cell lung cancer VA $30,000
Daniel A. Pollyea MD A dose escalation study of Ibrutinib with Lenalidomide for relapsed and refractory chronic lymphocytic leukemia/small lymphocytic lymphoma UCD $30,000
Joy Hesselberth PhD Defining the role of SF 381 mutations in Leukemia UCD $30,000
Cheng-Jun Hu PhD Role of HIF in regulating RNI splicing of HIF target genes UCD $30,000
Christopher Lieu MD Discovery of novel targets for young patients with colorectal cancer UCD $30,000
Andrew Thorburn MD with Paola Maybeth, Fellow Targeting autophagy for the treatment of triple negative breast cancer UCD $30,000
Michael Graner PhD Metabolomics of primary and recurrent high grade gilomas: a role for the UPR UCD $30,000
  TOTAL    $808,500

2012 Research Grants Awarded

2012 Research Grants Awarded

Download the 2012 CANCER LEAGUE OF COLORADO RESEARCH GRANTS as a .pdf

Pepper Schedin, PhD University of Colorado Denver
Investigating the role of lymphangiogenesis and lymphovascular invasion in metastasis of postpartum breast cancer
$30,000.00

Jingshi Shen, PhD
Dissection of the perforin pathway in cancer immunotherapy
$30,000.00
University of Colorado Boulder

Shi-Long Lu, PhD
Tumor cell Dissemination and Metastasis Initiation in Head and Neck Cancer
$30,000.00
University of Colorado Denver

Amanda Guth, DVM, PhD
Monocyte Blockade with CCR2 Antagonists for Inhibition of tumor metastases
$30,000.00
Colorado State University

Jill Slansky, PhD Tullio Bruno, PhD
Characterizing the Function and Location of B Cells in Lung Cancer
$30,000.00
University of Colorado Denver

Jordan Jacobelli, PhD
Regulation of lymphoma dissemination by the actin-myosin cytoskeleton
$30,000.00
National Jewish Health

Eduardo Pajon, MD
Colorado Cancer Research Program
$30,000.00
Presbyterian/St. Luke’s

Rui Zhao, PhD Quinghong Zhang, PhD
Inhibiting the transcriptional co-repressor CtBP for cancer therapy using cell penetrating peptide
$60,000.00
University of Colorado Denver

Catherine Musselman, PhD
The Role of PHF1 in the repressive activity of PRC2
$30,000.00
University of Colorado Denver

Ann Thor, MD/ Reema Wahdan-Alaswad, PhD
Metformin Inhibits Metastasis in Triple Negative Breast Cancer
$30,000.00
University of Colorado Denver

Marileila Varella Garcia, PhD
2012 Cancer Research Summer Fellowship Program
$30,000.00
University of Colorado Denver

Peter Kabos, MD
Role of alternative polyadenylation in estrogen receptor positive breast cancer
$30,000.00
University of Colorado Denver

Michael J. Morgan, PhD
Autophagy Dependence and Chloroquine Sensitivity in Metastatic Cancer
$30,000.00
University of Colorado Denver

Stephen Malkoski, MD Scott Cramer, PhD
Defining the role of TAK1 in non-small cell lung cancer
$60,000.00
University of Colorado Denver

Antonio Jimeno, MD, PhD Gregory Gan, MD, PhD
Resistance of Human Head and Neck Squamous Cell Carcinoma to Concurrent EGFR and Radiotherapy Mediated Through the Hedgehog Pathway
$30,000.00
University of Colorado Denver

Bolin Liu, MD
Epignetic induction of erbB2/erbB3-targeting miRNAs in breast cancer
$30,000.00
University of Colorado Denver

Robert Doebele, MD, PhD Kurtis D. Davies, PhD
Acquired Resistance to ROS1 inhibition in Non-Small Cell Lung Cancer: Identification of Cellular Mechanisms and Exploration of Alternative Treatment Strategies
$30,000.00
University of Colorado Denver

David Astling, PhD
Development of an Improved Classifier for Predicting Multiple Drug Classes and Molecular Targets for Tumor Subtypes
$30,000.00
University of Colorado Denver

Uday Kompella, PhD
Novel Lung Cancer Therapeutics
$30,000.00
University of Colorado Denver

Michelle Guney, PhD
The Role of Eya in breast cancer metastic progression
$30,000.00
University of Colorado Denver

Colin Moore, MD
Evaluating the Role of miR 193b in Ewing Sarcoma growth Suppression
$30,000.00
University of Colorado Denver

Caroline Kulesza, PhD
Virus Manipulation of a Cellular Chromatin Modifying Complex
$30,000.00
University of Colorado Denver
$720,000.00

2011 Research Grants Awarded

2011 Research Grants Awarded

2011 Awards

Steve Anderson, Ph.D.
University of Colorado Denver
Does cell surface transporter expression determine the response of breast cancer
$30,000

Sunshine Axlund, Ph.D.
University of Colorado Denver
Tumor initiating and Drug Resistant Properties of a minor Population of Stem-Like Cells in Explant Models of Estrogen Receptor Positive Human Breast Tumors
$30,000

Andrew Bradford, Ph.D.
University of Colorado Denver
PKCδ as a biomarker and regulator of response to chemotherapy in endometrial cancer
$30,000

Dawn Cochrane, Ph.D.
University of Colorado Denver
Restoring miR-200c to aggressive ovarian cancers to attack anoikis resistance
$30,000

Dawn Duval, Ph.D.
Colorado State University
Osteosarcoma: Biomarkers of Metastasis and Resistance to Therapy
$30,000
Kim Jihye, Ph.D.
University of Colorado Denver
PathCMap Development of pathway signature system for identifying partners of synethetic lethal genes
$30,000
James Lambert, Ph.D.
University of Colorado Denver
Genome-wide RA interference screen for mediators of cell death induced by a novel vitamin D analog in triple negative breast cancer
$30,000
Lindsay Micel, M.D.
University of Colorado Denver
Identifying mechanisms of resistance to the novel NAE inhibitor, MLN4924, in melanoma
$30,000

Christopher Porter, M.D. and Jean Mulcahy, M.D.
University of Colorado Denver UCD
High Throughput Functional Genetic Screening to Define the Role of Autophagy in Pediatric Brain Tumors
$60,000

Pajon, Eduardo, Jr., M.D.
CO Cancer Research Program
Colorado Cancer Research Clinical Trials Program
$30,000

Renee Paulson, Ph.D.
University of Colorado Boulder
Elucidating the cellular response to hypoxia via functional genomics
$30,000

Rytis Prekeris, Ph.D., and Pepper Schedin, Ph.D.
University of Colorado Denver
The regulation of MMP Secretion During the Invasion of Breast Cancer Cells
$60,000

Dylan Taatjes, Ph.D.
University of Colorado Boulder
Identification of transcriptional cofactors that trigger alternations in breast cancer pathology and therapeutic response
$30,000

Raul Torres, Ph.D.
University of Colorado Denver
LPA Regulation of T Cell Tumor Immunity
$30,000

Marileila Varella Garcia, Ph.D.
University of Colorado Denver
Cancer Research Summer Fellowship Program
$30,000
Henry Thompson, Ph.D. and Barbara Wallner, Ph.D.
Colorado State University
Competency Development to Reduce Obesity and Promote Long Term Survival Following treatment for Breast Cancer
$59,780
Quinghong Zhang, Ph.D.
University of Colorado Denver
The Role of CtBP1 in SCC
$30,000